Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=slxpLatest Financial News for Salix Pharmaceuticals, Ltd.en-usThu, 17 Dec 2009 07:00:31 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/ud?s=SLXPyahoo_finance/1056155156Thu, 17 Dec 2009 07:00:31 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091216/28384.html?.v=1yahoo_finance/3318642622Wed, 16 Dec 2009 16:52:23 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12c2pjep4/*http%3A//triangle.bizjournals.com/triangle/stories/2009/12/07/daily62.html?ana=yfcpcyahoo_finance/675025808Fri, 11 Dec 2009 18:05:20 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091210/slxp8-k.htmlyahoo_finance/4236266020Thu, 10 Dec 2009 21:34:04 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091210/20091210005524.html?.v=1RALEIGH, N.C.----Salix Pharmaceuticals, Ltd. today reported that the Company held a pre-NDA meeting on December 8, 2009 with the FDA to discuss the Company’s proposed new drug application for rifaximin in the treatment of patients with non-constipation irritable bowel syndrome .yahoo_finance/1798179195Thu, 10 Dec 2009 14:31:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091124/slxp8-k.htmlyahoo_finance/4016116802Tue, 24 Nov 2009 19:43:56 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091124/20091124005038.html?.v=1RALEIGH, N.C.----Salix Pharmaceuticals, Ltd. today announced that the Company will present at the Piper Jaffray 21st Annual Health Care Conference in New York, NY on Tuesday, December 1 at 10:00 a.m.yahoo_finance/912788877Tue, 24 Nov 2009 12:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091123/us_salix_pharmaceuticals_stock_offering.html?.v=2Salix Pharmaceuticals Ltd. said Monday it completed its public offering of 5.5 million shares of common stock. The company announced the offer Nov. 18. It offered the stock at $21 per share.yahoo_finance/2195915533Mon, 23 Nov 2009 19:45:26 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091123/slxp8-k.htmlyahoo_finance/2308460107Mon, 23 Nov 2009 18:12:09 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12b9hrpqc/*http%3A//triangle.bizjournals.com/triangle/stories/2009/11/23/daily8.html?ana=yfcpcyahoo_finance/3952846476Mon, 23 Nov 2009 18:05:17 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091123/20091123005920.html?.v=1RALEIGH, N.C.----Salix Pharmaceuticals, Ltd. , a specialty pharmaceutical company, today announced it has closed its previously announced public offering of 5,500,000 shares of its common stock at a price of $21.00 per share.yahoo_finance/1355762513Mon, 23 Nov 2009 16:50:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091119/slxp8-k.htmlyahoo_finance/2264251378Thu, 19 Nov 2009 11:01:59 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=1358nvdmt/*http%3A//www.fool.com/investing/international/2009/11/18/build-your-fortune-with-these-winners.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/4050647487Wed, 18 Nov 2009 20:21:43 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091118/us_salix_stock_offering.html?.v=1Salix Pharmaceuticals Ltd. said Wednesday it is publicly offering 5.5 million shares of common stock. The company is giving underwriters a 30-day option to buy up to an additional 825,000 shares to cover overallotments.yahoo_finance/2706623781Wed, 18 Nov 2009 16:18:10 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091118/20091118005697.html?.v=1RALEIGH, N.C.----Salix Pharmaceuticals, Ltd. , a specialty pharmaceutical company, today announced the pricing of a public offering of 5,500,000 shares of its common stock. The offering is expected to close on or about November 23, 2009, subject to customary closing conditions.yahoo_finance/1410408312Wed, 18 Nov 2009 14:09:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=slxpyahoo_finance/3822274121Fri, 13 Nov 2009 14:05:45 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091111/27191.html?.v=1yahoo_finance/3354676155Wed, 11 Nov 2009 20:56:56 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12c29ok92/*http%3A//triangle.bizjournals.com/triangle/stories/2009/11/09/daily21.html?ana=yfcpcyahoo_finance/3523267257Tue, 10 Nov 2009 12:05:14 Etc/GMThttp://us.rd.yahoo.com/finance/external/trsa/rss/SIG=135aijbk4/*http%3A//seekingalpha.com/article/172354-salix-pharmaceuticals-ltd-q3-2009-earnings-call-transcript?source=yahooyahoo_finance/1378091610Tue, 10 Nov 2009 03:00:30 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091109/us_earns_salix_pharmaceuticals.html?.v=1Salix Pharmaceuticals Ltd. said Monday its loss widened in the third quarter on increased research and development and sales costs.yahoo_finance/2235977482Mon, 9 Nov 2009 23:21:24 Etc/GMT